Stock IMMUTEP LTD
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Immutep Ltd Australian S.E.

Equities

AU000000PRR9

Chart calendar Immutep Ltd

12acd4aafd4b.yxHgQ9JVYp153i4ktLGl-eFYFLspPojSbmnRRlA3eZo.rk66B6MmAfI-uHQT-8f_gNE9Oc1FT9iVOTPmBClhCdW6Qogy6gw26TK4fw~27d6b6a71628083e6e32218406a8ef53

Upcoming events on Immutep Ltd

14/05/2024 European Society for Medical Oncology Meeting
30/05/2024 American Society of Clinical Oncology Annual Meeting
27/08/2024 Q4 2024 Earnings Release (Projected)
19/02/2025 Q2 2025 Earnings Release (Projected)
26/08/2025 Q4 2025 Earnings Release (Projected)
18/02/2026 Q2 2026 Earnings Release (Projected)

Past events on Immutep Ltd

27/02/2024 22:39 Q2 2024 Earnings Release
16/02/2024 01:30 ShareCafe Hidden Gems Webinar
06/02/2024 04:40 Euroz Hartleys Healthcare Forum
29/01/2024 21:32 December 2023 Sales and Revenue Release - Activities Report
07/01/2024 JPMorgan Healthcare Conference
15/11/2023 15:00 Jefferies London Healthcare Conference
13/11/2023 Immuno-Oncology Europe Conference
09/11/2023 15:30 Baird Biotech Discovery Series
03/11/2023 16:00 Society for Immunotherapy of Cancer Meeting - Abstract Number: 595
03/11/2023 16:00 Society for Immunotherapy of Cancer Meeting - Abstract Number : 595
31/10/2023 AusBiotech Conference
31/10/2023 12:00 September 2023 Sales and Revenue Release - Activities Report
24/10/2023 Wilsons Drug and Device Healthcare Conference
24/10/2023 00:30 Annual General Meeting
22/10/2023 European Society for Medical Oncology Congress - Poster No: 1987TiP
22/10/2023 European Society for Medical Oncology Congress - Poster No: 1042P
22/10/2023 22:00 European Society for Medical Oncology Congress
21/10/2023 08:05 European Society for Medical Oncology Congress - Abstract No: 2174
26/09/2023 19:45 Cantor Global Healthcare Conference
13/09/2023 06:50 E&P Small Caps Conference

Annual results

Fiscal PeriodJune 2019 2020 2021 2022 2023 2024
Net sales
Million AUD		Released
Forecast
Spread 		7,49
0,00
- 		16,5
13,0
26.47%		0,00
4,95
- 		6,76
4,04
67.13%		5,20
6,15
-15.41%
3,19

EBITDA
Million AUD		Released
Forecast
Spread 		-18,3
-7,55
-142.58%		0,00
0,00
- 		-17,6
-19,1
7.93%		-30,1
-35,5
15.3%		-37,8
-41,3
8.49%
-47,0

EBIT
Million AUD		Released
Forecast
Spread 		-20,2
-15,0
-34.9%		-12,3
-15,6
20.94%		-19,7
-24,1
18.34%		-32,1
-36,9
12.9%		-39,9
-44,2
9.86%
-47,4

Earnings before Tax (EBT)
Million AUD		Released
Forecast
Spread 		-18,3
-18,5
0.96%		-13,5
-15,4
12.69%		-29,9
-30,8
2.83%		-32,2
-36,8
12.45%		-39,9
-43,4
8.08%
-45,9

Net income
Million AUD		Released
Forecast
Spread 		-18,3
-12,8
-43.47%		-13,5
-15,4
12.47%		-29,9
-30,8
2.83%		-32,2
-36,8
12.45%		-39,9
-43,4
8.08%
-45,2

EPS
AUD		Released
Forecast
Spread 		-0,06
-0,03
-90%		-0,03
0,00
-1020%		-0,05
-0,04
-13.93%		-0,04
-0,04
12.63%		-0,04
-0,04
-3%
-0,04

Announcement Date20/08/1925/08/2030/08/2131/08/2229/08/23-

Quarterly results

Fiscal PeriodJune 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2
Net sales
Million AUD		Released
Forecast
Spread





0,00
0,00
- 		0,00
1,08
- 		2,08
1,40
48.57%		3,91
3,20
22.07%


2,62
3,23
-19.05%		4,11
2,10
95.73%
0,67

EBITDA
Million AUD		Released
Forecast
Spread





-9,34
-9,40
0.62%		-8,24
-9,70
15%		-15,0
-15,1
0.99%		-15,7
-16,2
3.21%
-19,7


-21,8


-23,8


-26,0

EBIT
Million AUD		Released
Forecast
Spread 		-5,37
-5,10
-5.37%		-6,94
-9,52
27.09%		-10,4
-12,3
15.38%		-9,26
-13,5
31.62%		-16,8
-15,1
-11.65%		-15,9
-17,9
11.42%		-20,6
-19,0
-8.69%		-19,3
-22,6
14.77%		-21,2
-23,9
11.13%
-26,2

Earnings before Tax (EBT)
Million AUD		Released
Forecast
Spread 		-5,95
-5,10
-16.69%		-7,52
-9,57
21.42%		-19,8
-14,1
-41.17%		-10,1
-15,3
34.43%		-16,3
-15,1
-8.1%		-15,9
-18,0
11.44%		-20,6
-19,2
-7.18%		-19,3
-21,2
9.06%		-21,2
-23,7
10.48%
-25,3

Net income
Million AUD		Released
Forecast
Spread 		-5,95
-5,10
-16.7%		-7,52
-9,52
21%		-19,8
-14,1
-41.17%		-10,1
-15,3
34.43%		-16,3
-15,1
-8.1%		-15,9
-18,1
11.69%		-20,6
-12,8
-60.78%		-19,3
-21,9
11.98%		-21,2
-23,7
10.48%
-25,0

EPS
AUD		Released
Forecast
Spread





-0,04
-0,04
4.25%		-0,01
-0,03
52%		-0,02
-0,02
0%		-0,02
-0,02
15.91%		-0,02
-0,02
-2.61%


-0,02
-0,02
14.76%
-0,02

Announcement Date20/02/2025/08/2023/02/2130/08/2124/02/2331/08/2224/02/2329/08/2327/02/24-

Upcoming sector events for Immutep Ltd

28/04/2024 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected)
28/04/2024 SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release
28/04/2024 JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release
28/04/2024 MORPHOSYS AG: Q1 2024 Earnings Release
29/04/2024 21:05 QIAGEN N.V.: Q1 2024 Earnings Release
29/04/2024 CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected)
30/04/2024 DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 AZENTA, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Immutep Ltd

26/04/2024 GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release
26/04/2024 GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release
26/04/2024 06:00 BB BIOTECH AG: Q1 2024 Earnings Release
25/04/2024 BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release
25/04/2024 PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release
25/04/2024 HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected)
25/04/2024 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release
25/04/2024 CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release
25/04/2024 12:00 MORPHIC HOLDING, INC.: Q1 2024 Earnings Release
25/04/2024 07:00 PURETECH HEALTH PLC: Q4 2023 Earnings Release
  1. Stock Market
  2. Equities
  3. IMM Stock
  4. Stock
  5. Calendar Immutep Ltd